Invention Grant
- Patent Title: Pyrimidine derivatives
- Patent Title (中): 嘧啶衍生物
-
Application No.: US12711364Application Date: 2010-02-24
-
Publication No.: US08420630B2Publication Date: 2013-04-16
- Inventor: Georg Dahmann , Frank Himmelsbach , Bernd Krist , Martin Lenter , Alexander Pautsch , Gisela Schnapp , Martin Steegmaier , Helmut Wittneben , Anthony S. Prokopowicz , Walter Spevak , Andreas Schoop , Steffen Steurer
- Applicant: Georg Dahmann , Frank Himmelsbach , Bernd Krist , Martin Lenter , Alexander Pautsch , Gisela Schnapp , Martin Steegmaier , Helmut Wittneben , Anthony S. Prokopowicz , Walter Spevak , Andreas Schoop , Steffen Steurer
- Applicant Address: DE Ingelheim am Rhein US CT Ridgefield
- Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG,Boehringer Ingelheim Pharmaceuticals, Inc.
- Current Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG,Boehringer Ingelheim Pharmaceuticals, Inc.
- Current Assignee Address: DE Ingelheim am Rhein US CT Ridgefield
- Agent Michael P. Morris; Philip I. Datlow
- Main IPC: C07D239/48
- IPC: C07D239/48 ; C07D403/12 ; C07D401/12 ; A61K31/506
Abstract:
The present invention relates to trisubstituted pyrimidines of formula (I) wherein 0Ra to Re are defined as in claim 1, which are suitable for the treatment of illnesses characterized by excessive or abnormal cell proliferation, the use thereof for preparing a pharmaceutical composition with the abovementioned properties, and processes for the preparation thereof.
Public/Granted literature
- US20100152167A1 PYRIMIDINE DERIVATIVES Public/Granted day:2010-06-17
Information query
